ClinicalTrials.govpublic full text
Study Comparing the Standard Administration of IO Versus the Same IO Administered Each 3 Months in Patients in Response After 6 Months of Standard IO
lung cancer metastatic, renal cell carcinoma, head and neck cancer, triple negative breast cancer, merkel cell carcinoma, hepatocellular carcinoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 141014
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.